Robert J. Schmittling

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

John H. Sampson, Amy B. Heimberger, Gary E. Archer et al. · Journal of Clinical Oncology · 2010 · 808 citations · Full text

Medicine, Immunology, Oncology +17

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

Duane A. Mitchell, Weihua Xie, Robert J. Schmittling et al. · Neuro-Oncology · 2007 · 389 citations · Full text

Medicine, Oncology, Pathology +15

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

John H. Sampson, Kenneth Aldape, Gerald E. Archer et al. · Neuro-Oncology · 2010 · 369 citations · Full text

Medicine, Immunology, Oncology +17

EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez et al. · Clinical Cancer Research · 2013 · 293 citations

Life Sciences, Immunology, Oncology +17

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer et al. · Clinical Cancer Research · 2017 · 288 citations · Full text

Medicine, Immunology, Oncology +17